Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting
Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure…
EnteroBiotix Announces Oral Presentation of Phase 2a IBS-C Results at Digestive Disease Week 2025
April 28, 2025 03:00 ET | Source: EnteroBiotix EnteroBiotix Announces Oral Presentation…
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
Met primary endpoint of safety and tolerability in CCM patients with no…
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohns and Colitis Congress
February 04, 2025 07:00 ET | Source: Shattuck Labs, Inc. AUSTIN, TX…
Outlook Therapeutics Announces Presentation of Efficacy and Safety Results from NORSE EIGHT Clinical Trial Evaluating ONS-5010 for the Treatment of Wet AMD
Data presented at Hawaiian Eye and Retina 2025 MeetingResults confirmed that intravitreal…
Zefiro Methane Corp. Releases Updated Corporate Presentation Reflecting 2024 Growth
FORT LAUDERDALE, Fla., Jan. 09, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP.…
Avid Bioservices Files Investor Presentation HighlightingValue Maximizing Transaction with GHO and Ampersand
Avid Urges Stockholders to Vote FOR the Pending Transaction TODAY January 08,…
Immuron CEO, Steven Lydeamore presentation to21st Virtual Investor Summit Microcap Event
MELBOURNE, Australia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC;…
The Shaw Prize Award Presentation Ceremony 2024: 21 Years of Celebrating Excellence in Scientific Achievements
HONG KONG, Nov. 12, 2024 /PRNewswire/ -- The Shaw Prize presented its…
The Shaw Prize Award Presentation Ceremony 2024: 21 Years of Celebrating Excellence in Scientific Achievements
HONG KONG, Nov. 12, 2024 /PRNewswire/ -- The Shaw Prize presented its…